Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier and more sustainable. From the food you eat, to the water you drink, to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate.
Eurofins is the global leader in food, environment, pharmaceutical and cosmetic product testing and in agroscience Contract Research Organisation services. Eurofins is one of the market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and in the support of clinical studies, as well as having an emerging global presence in Contract Development and Manufacturing Organisations. The Group also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products.
In over just 30 years, Eurofins has grown from one laboratory in Nantes, France to 55,000 staff across a decentralised and entrepreneurial network of 900 laboratories in over 50 countries. Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products.
Eurofins Transplant Genomics Inc. (“ETG”) is a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive serial monitoring guided by biomarkers. ETG’s product portfolio of both individual and combined whole blood gene expression and donor derived cell-free DNA testing is capable of reliably ruling out subclinical kidney rejection and acute rejection in kidney transplant patients. In addition to kidney transplantation testing, our newest product for liver transplant patients is a blood-based biomarker assay designed to rule out rejection as immunosuppression therapy is optimized.
Basic Function and Scope of Responsibility:
The National Accounts Manager – (NAM) focuses on building and maintaining relationships with large healthcare organizations, including hospitals and health systems. The individual will drive strategic growth working with C-suite executives and transplant teams by identifying and building strong relationships with key decision makers to promote the entire suite of ETG’s offerings.
Expectations/ Responsibilities:
- Drive the business by focusing on relationships with key strategic Integrated Delivery Networks, Academic Centers, VAs and Large Health Systems across the US.
- Effectively work collaboratively with ETG territory managers in order to help maximize potential business opportunities and partnerships.
- Implement strategic account plans and best practices based on field insights, market assessments, and trends.
- Identify and manage RFP, GPO, and contracting opportunities within major health systems.
- Establish relationships with executive leadership at Key accounts (C- Suite, President, Transplant Center Leadership, Executive Leaders, etc) to cultivate opportunities for collaboration.
- Build relationships with purchasing and contracting teams to help leverage opportunities to promote ETG’s products.
- Establish positive working relationships with all key customer segments (internal and external).
- Travel up to 50% for customer and team engagements.
Lenexa, Kansas
Full Time